Researchers at Baylor College of Medicine’s Medical Genetics Laboratories will use Illumina’s Infinium® High-Density DNA Analysis products to study genomic imprinting and its role in developmental diseases such as Prader-Willi syndrome, Angelman syndrome, and other disorders caused by uniparental disomy.
With the Infinium DNA Analysis products, scientists at Baylor will have access to high-resolution scans of entire genomes for chromosomal abnormalities found in genes and disease pathways linked to common developmental diseases and syndromes, according to the company. These products are reported to offer quick and cost-effective screening for single-nucleotide polymorphisms associated with diseases, structural variation, and copy-neutral loss of heterozygosity events such as uniparental disomy.